Insights and news

Stephenson Harwood advises Shield Therapeutics plc on exclusive Japan licence

Law firm Stephenson Harwood LLP has advised Shield Therapeutics plc on its exclusive licence agreement with VITAL-NET, Inc. for ACCRUFeR® in Japan.

Read more Insight

Kristian Shearsby joins Stephenson Harwood as partner

Law firm Stephenson Harwood LLP has strengthened its corporate finance practice, and life sciences and technology sector capabilities, with the arrival of Kristian Shearsby as partner in its London office.

Read more News
F is for foreign investment: UK’s new foreign investment screening regime – What you need to know?

Life sciences A to Z - F is for foreign investment: UK’s new foreign investment screening regime – What you need to know?

Read more Insight
E is for equity investment

Life sciences A to Z - E is for equity investment

Read more Insight
Cybersecurity in the life sciences industry: Fail to prepare; prepare to fail

Cybersecurity in the life sciences industry: Fail to prepare; prepare to fail

Read more Insight
D is for data opt-out

Life sciences A to Z - D is for data opt-out

Read more Insight
COVID-19 vaccine patent waivers

COVID-19 vaccine patent waivers

Read more Insight
C is for collaboration arrangements

Life sciences A to Z - C is for collaboration arrangements

Read more Insight
Life sciences - Still in the antitrust spotlight

Life sciences - Still in the antitrust spotlight

Read more Insight
UK Public Procurement Reform in the life sciences sector – What's the latest?

UK Public Procurement Reform in the life sciences sector – What's the latest?

Read more Insight
D-day announced – UK's new National Security and Investment Act regime to begin on 4 January 2022

D-day announced – UK's new National Security and Investment Act regime to begin on 4 January 2022

Download PDF Insight
Changes to the Listing Rules - SPACs

Changes to the Listing Rules - SPACs

Read more Insight
B is for Biologics License Application

Life sciences A to Z - B is for Biologics License Application

Read more Insight
A for Artificial Intelligence

Life sciences A to Z - A is for Artificial Intelligence

Read more Insight

Stephenson Harwood advises Apposite Capital on Emblation investment

Law firm Stephenson Harwood LLP has advised healthcare investor Apposite Capital on its investment in medical device company, Emblation.

Read more News

Stephenson Harwood advises e-therapeutics plc on £22.5 million fundraise

Law firm Stephenson Harwood LLP has advised e-therapeutics plc on a fundraise of £22.5 million.

Read more News